Because Sangamo Chief Executive Edward Lanphier obtained exclusive licenses from the handful of academics working on zinc-finger proteins, Sangamo has a near lock on patents relating to zinc-finger proteins.

FORBES: Gene Drugs For Untreatable Diseases